Horizon Therapeutics Public Limited Company HZNP
$ 116.3
0.0%
Quarterly report 2023-Q2
added 08-08-2023
Country |
Irlanda |
IPO year |
2011 |
Industry |
Drug manufacturers |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Mr. Timothy Walbert |
Employees in the company |
1 275 |
Shares |
229 M |
Market Cap[1] |
$ 26.6 B |
EBITDA (LTM) |
$ 827 M |
P/E (LTM) |
62.7 |
P/S (LTM) |
6.66 |
EPS (LTM) |
1.66 |
Other stocks of industry "Drug manufacturers"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.